IPO Proposal of Yambaling Hydropower Limited And Sopan Pharmaceuticals Limited Approved by SEBON
Summary
SEBON has approved the IPO proposals for Yambaling Hydropower Limited and Sopan Pharmaceuticals Limited, with shares offered to the public and ratings by CARE Ratings Nepal Limited.
Key Points
- SEBON approved the IPO proposal of Yambaling Hydropower Limited to issue 2.8 million shares at Rs. 100 each.
- Yambaling Hydropower operates a 7.27 MW run-of-river project in Sindhupalchowk, Nepal, started commercial operations in February 2024.
- SEBON approved the IPO proposal of Sopan Pharmaceuticals Limited to issue 4.29 million shares at Rs. 100 each.
- CARE Ratings Nepal Limited assigned issuer ratings to both companies, indicating moderate risk for Yambaling and high risk for Sopan Pharmaceuticals.
